News Strategy for post-Brexit life science sector unveiled Plan aims to solve long-standing issue of access to medicines
News Show ambition with UK life sciences plan, Novartis tells gov... Drugmaker concerned over access to new drugs
News England looks to EU doctors to fill shortage England’s health service is stepping up recruitment of doctors from overseas in order to fill a huge shortage in primary care – with European Union countries being the main target.
News Pharma welcomes UK's post-Brexit trade plans UK pharma and biotech trade bodies have welcomed government proposals to ensure trade and services can continue after Brexit in March 2019.
News Government outlines plans to boost doctor training But BMA warns more must be done to prevent Brexit brain-drain.
News Deadline looms for EMA host city bids Europe's medicines regulator will move from London after Brexit
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
